Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs) EQUITY
$61.79
neg -2.60
-4.10%
Today's Range: 61.73 - 64.52 | TEVA Avg Daily Volume: 5,570,500
Last Update: 04/27/15 - 2:54 PM EDT
Volume: 5,973,744
YTD Performance: 12.00%
Open: $63.60
Previous Close: $64.41
52 Week Range: $47.36 - $68.75
Oustanding Shares: 851,871,888
Market Cap: 53,880,896,916
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 12 11 11
Moderate Buy 1 1 1 1
Hold 7 9 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.71 1.86 1.95 1.95
Latest Dividend: 0.29
Latest Dividend Yield: 1.82%
Dividend Ex-Date: 02/17/15
Price Earnings Ratio: 42.45
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
42.45 17.80 28.22
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.57% 29.23% 42.03%
GROWTH 12 Mo 3 Yr CAGR
Revenue -0.20 0.11 0.03
Net Income 142.80 0.10 0.03
EPS 138.50 0.15 0.05
Earnings for TEVA:
EBITDA 6.00B
Revenue 20.27B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $1.26 $1.28 $5.16 $5.10
Number of Analysts 12 11 18 17
High Estimate $1.34 $1.32 $5.30 $5.38
Low Estimate $1.20 $1.23 $5.03 $4.46
Prior Year $1.22 $1.23 $5.07 $5.16
Growth Rate (Year over Year) 3.01% 3.77% 1.69% -1.07%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Partnerships Lift Small Caps Real Money Pro($)

Watch for small biotechs partnering with bigger firms.
And four other things you need to know now.
U.S. stocks were mixed on Tuesday.
Biotech companies are saying, "I do."
Teva bid highlights M&A action in health care sector.
Teva bid highlights M&A action in health care sector.
These companies are the hottest thing going.
Recent activity has heated up and is creating shareholder value.
In breakout mode, the stock is looking to continue its upward path.
With so much M&A action, now's the time to invest in the sector.

Columnist Conversations

I am going into the Apple EPS report with a small short position.
From a near-term technical perspective, let's notice that Apple Inc. (AAPL) has emerged from its Feb-Apr corre...
Recent buy, Ford, looks like it might be attempting a "breakout."
Industrial manufacturer Valmont Industries (VMI) has had nothing but bad news over the last year or so. The st...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.